Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

502
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
502

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting IL-17 family cytokines and receptors in hepatocellular carcinoma: From biology to combination immunotherapy.

Biochimica et biophysica acta. Reviews on cancer·2026
Same author

A systematic guide for identifying transcription factors that directly regulate the expression of a gene of interest.

Genome research·2026
Same author

Design, Synthesis, and Biological Activity of (<i>E</i>)-α-Fluorovinylphosphonate-Based Reversible Cathepsin C Inhibitors.

The Journal of organic chemistry·2026
Same author

Ag Microparticle/Au Nanoparticle Thermal Interface Materials Sintered at Low Temperature and Pressure.

Materials (Basel, Switzerland)·2025
Same author

Indole-Pyrazole Hybrids: Synthesis, Structure, and Assessment of Their Hemolytic and Cytoprotective Properties.

International journal of molecular sciences·2025
Same author

Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design Platform.

ACS medicinal chemistry letters·2025

Related Experiment Video

Updated: Jun 10, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

440

QSPRmodeler - An open source application for molecular predictive analytics.

Rafał A Bachorz1, Damian Nowak1,2, Marcin Ratajewski1

  • 1Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.

Frontiers in Bioinformatics
|October 11, 2024
PubMed
Summary

This study introduces Python software for in silico drug design, utilizing machine learning to predict molecular properties. The tool streamlines data processing and model training for faster drug candidate evaluation.

Keywords:
ADMETQSPRbiological activitydrug designmachine learning

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.9K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.6K

Related Experiment Videos

Last Updated: Jun 10, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

440
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.9K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.6K

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Drug discovery

Background:

  • In silico methods are crucial for efficient drug design.
  • Molecular property prediction is a key early-stage drug discovery task.
  • Machine learning models require experimental data for training.

Purpose of the Study:

  • To develop Python software for supporting the drug design process.
  • To facilitate molecular property prediction using machine learning.
  • To enable the comparison of drug candidates with experimental data.

Main Methods:

  • Development of a Python software package for molecular data processing.
  • Implementation of machine learning workflows for predictive model training.
  • Internal and external validation of predictive model capabilities.

Main Results:

  • The software supports the end-to-end workflow from data preparation to model training.
  • Validated predictive models can be applied to new chemical compounds.
  • The models integrate with complex workflows, including generative approaches.

Conclusions:

  • The developed Python software effectively supports in silico drug design.
  • Machine learning-based molecular property prediction accelerates candidate evaluation.
  • The tool enhances the efficiency of early-stage drug discovery pipelines.